{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:24:54Z","timestamp":1761157494132,"version":"3.44.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ad.2023.02.011","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T12:15:45Z","timestamp":1677413745000},"page":"T308-T317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["[Translated article] Haptens, Proteins, and Atopic Dermatitis"],"prefix":"10.1016","volume":"114","author":[{"given":"V.","family":"Amat-Samaranch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Silvestre Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.02.011_bib0330","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC phase three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0335","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaci.2013.08.031","article-title":"Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study","volume":"132","author":"Silverberg","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0340","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12016-018-8711-2","article-title":"Contact dermatitis in atopic dermatitis children \u2013 past, present, and future","volume":"56","author":"Borok","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0345","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","article-title":"Comorbidities and the impact of atopic dermatitis","volume":"123","author":"Silverberg","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0350","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40257-017-0340-7","article-title":"The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis","volume":"19","author":"Owen","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.36849\/JDD.2020.4737","article-title":"Atopic dermatitis: a review of current diagnostic criteria and a proposed update to management","volume":"19","author":"Reynolds","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.12432","article-title":"European Society of Contact Dermatitis guideline for diagnostic patch testing \u2013 recommendations on best practice","volume":"73","author":"Johansen","year":"2015","journal-title":"Contact Dermatitis"},{"issue":"Suppl. 92","key":"10.1016\/j.ad.2023.02.011_bib0365","first-page":"44","article-title":"Diagnostic features of atopic dermatitis","author":"Hanifin","year":"1980","journal-title":"Acta Dermatoever"},{"key":"10.1016\/j.ad.2023.02.011_bib0370","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2015.02.1139","article-title":"Allergic contact dermatitis: patient diagnosis and evaluation","volume":"74","author":"Mowad","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0375","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-021-00271-4","article-title":"Contact dermatitis","volume":"7","author":"Scheinman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ad.2023.02.011_bib0380","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response","volume":"134","author":"Dhingra","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0385","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaip.2014.05.004","article-title":"The role of contact dermatitis in patients with atopic dermatitis","volume":"2","author":"Aquino","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ad.2023.02.011_bib0390","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.clindermatol.2017.03.009","article-title":"Contact dermatitis considerations in atopic dermatitis","volume":"35","author":"Rundle","year":"2017","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0395","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaad.2018.07.017","article-title":"Allergic contact dermatitis to personal care products and topical medications in adults with atopic dermatitis","volume":"79","author":"Rastogi","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0400","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archderm.1990.01670330053005","article-title":"Contact sensitivity to dinitrochlorobenzene is impaired in atopic subjects. Controversy revisited","volume":"126","author":"Rees","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0405","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/jid.2013.148","article-title":"Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis","volume":"133","author":"Newell","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0410","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.15628","article-title":"Contact allergy in children with atopic dermatitis: a systematic review","volume":"177","author":"Simonsen","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0415","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaad.2017.02.001","article-title":"Association between atopic dermatitis and contact sensitization: a systematic review and meta-analysis","volume":"77","author":"Hamann","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0420","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archderm.1989.01670150056006","article-title":"A longitudinal study of contact sensitivity in patients with atopic dermatitis","volume":"125","author":"Uehara","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0425","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2340\/0001555556135138","article-title":"Patch testing, tuberculin testing and sensitization with dinitrochlorobenzene and nitrosodimethylanilini of patients with atopic dermatitis","volume":"56","author":"Forsbeck","year":"1976","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2023.02.011_bib0430","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/DER.0000000000000208","article-title":"A pragmatic approach to patch testing atopic dermatitis patients: clinical recommendations based on expert consensus opinion","volume":"27","author":"Chen","year":"2016","journal-title":"Dermatitis"},{"key":"10.1016\/j.ad.2023.02.011_bib0435","doi-asserted-by":"crossref","first-page":"78","DOI":"10.18176\/jiaci.0138","article-title":"Atopic dermatitis in adults: a diagnostic challenge","volume":"27","author":"Silvestre Salvador","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0440","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/DER.0b013e318275969f","article-title":"Effects of immunomodulatory agents on patch testing: expert opinion 2012","volume":"23","author":"Fowler","year":"2012","journal-title":"Dermatitis"},{"key":"10.1016\/j.ad.2023.02.011_bib0445","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jaci.2014.11.017","article-title":"Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin","volume":"135","author":"Correa da Rosa","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0450","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamadermatol.2017.3046","article-title":"Consumer preferences, product characteristics, and potentially allergenic ingredients in best-selling moisturizers","volume":"153","author":"Xu","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0455","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1398-9995.2008.01890.x","article-title":"Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children","volume":"64","author":"Mailhol","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2023.02.011_bib0460","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jamadermatol.2016.6136","article-title":"Pediatric contact dermatitis registry data on contact allergy in children with atopic dermatitis","volume":"153","author":"Jacob","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0465","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaad.2016.03.010","article-title":"Inflamed skin predisposes to sensitization to less potent allergens","volume":"75","author":"Kohli","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0470","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaad.2013.12.009","article-title":"Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to surfactants","volume":"70","author":"Shaughnessy","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0475","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cod.12035","article-title":"Sensitization patterns in Compositae-allergic patients with current or past atopic dermatitis","volume":"68","author":"Paulsen","year":"2013","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ad.2023.02.011_bib0480","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2310\/6620.2009.08081","article-title":"Positive patch test reactions to lanolin: cross-sectional data from the north american contact dermatitis group, 1994\u20132006","volume":"20","author":"Warshaw","year":"2009","journal-title":"Dermatitis"},{"key":"10.1016\/j.ad.2023.02.011_bib0485","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0536.2011.01898.x","article-title":"Prevalence of and factors influencing sensitization to corticosteroids in a Danish patch test population","volume":"64","author":"Vind-Kezunovic","year":"2011","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ad.2023.02.011_bib0490","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/1346-8138.12866","article-title":"Contact sensitivity in patients with recalcitrant atopic dermatitis","volume":"42","author":"Tamagawa-Mineoka","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0495","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaad.2013.03.012","article-title":"Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis","volume":"69","author":"Malajian","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0500","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cod.13363","article-title":"Allergic contact dermatitis in atopic individuals: results of a 30-year retrospective study","volume":"81","author":"Teo","year":"2019","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ad.2023.02.011_bib0505","doi-asserted-by":"crossref","first-page":"3946084","DOI":"10.1155\/2020\/3946084","article-title":"The effect of atopy in the prevalence of contact sensitization: the experience of a Greek referral center","volume":"2020","author":"Tagka","year":"2020","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.ad.2023.02.011_bib0510","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/jid.2013.445","article-title":"Filaggrin is a predominant member of the denaturation-resistant nickel-binding proteome of human epidermis","volume":"134","author":"Ross-Hansen","year":"2014","journal-title":"J Invest Dermatol"},{"unstructured":"Ficha tecnica Dupixent 300mg solucion inyectable en jeringa precargada. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1171229006\/FT_1171229006.html [accessed 12.6.22].","key":"10.1016\/j.ad.2023.02.011_bib0515"},{"key":"10.1016\/j.ad.2023.02.011_bib0520","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jaad.2021.02.044","article-title":"Effect of dupilumab on allergic contact dermatitis and patch testing","volume":"84","author":"Jo","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0525","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2018.07.043","article-title":"Dupilumab use in allergic contact dermatitis","volume":"80","author":"Machler","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0530","doi-asserted-by":"crossref","first-page":"e12701","DOI":"10.1111\/dth.12701","article-title":"A case series of dupilumab-treated allergic contact dermatitis patients","volume":"31","author":"Goldminz","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.02.011_bib0535","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cod.13266","article-title":"Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema","volume":"81","author":"Crepy","year":"2019","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ad.2023.02.011_bib0540","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaad.2019.09.028","article-title":"The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: a retrospective chart review","volume":"82","author":"Raffi","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0545","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaad.2018.12.048","article-title":"A retrospective review of dupilumab for atopic dermatitis patients with allergic contact dermatitis","volume":"80","author":"Chipalkatti","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0550","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaad.2019.03.020","article-title":"Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis","volume":"81","author":"Stout","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0555","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.jaad.2020.05.036","article-title":"Dupilumab for allergic contact dermatitis and implications for patch testing: Irreconcilable differences","volume":"83","author":"Shah","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0560","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12016-018-8687-y","article-title":"Food-related contact dermatitis, contact urticaria, and atopy patch test with food","volume":"56","author":"Walter","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0565","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ad.2011.02.005","article-title":"Protein contact dermatitis: review of 27 cases","volume":"102","author":"Hern\u00e1ndez-Bel","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2023.02.011_bib0570","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1398-9995.2011.02728.x","article-title":"Practical guide to skin prick tests in allergy to aeroallergens","volume":"67","author":"Bousquet","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2023.02.011_bib0575","first-page":"22","article-title":"The role of airborne proteins in atopic dermatitis","volume":"3","author":"Hostetler","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ad.2023.02.011_bib0580","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2004.02.005","article-title":"FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro","volume":"113","author":"Novak","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0585","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/pai.13127","article-title":"Epicutaneous sensitization to food allergens in atopic dermatitis: What do we know?","volume":"31","author":"Tham","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0590","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1398-9995.2000.00464.x","article-title":"The atopy patch test (APT) \u2013 a useful tool for the diagnosis of food allergy in children with atopic dermatitis","volume":"55","author":"Niggemann","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2023.02.011_bib0595","first-page":"3554","article-title":"Mite allergy and atopic dermatitis: is there a clear link? (Review)","volume":"20","author":"Bumbacea","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ad.2023.02.011_bib0600","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaip.2018.11.006","article-title":"Controversies in allergy: food testing and dietary avoidance in atopic dermatitis","volume":"7","author":"Robison","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ad.2023.02.011_bib0605","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.2500\/aap.2021.42.200126","article-title":"Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis","volume":"42","author":"Zhou","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.ad.2023.02.011_bib0610","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11882-019-0893-z","article-title":"Allergen immunotherapy and atopic dermatitis: the good, the bad, and the unknown","volume":"19","author":"Rizk","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.ad.2023.02.011_bib0615","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.02.011_bib0620","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/jdv.16892","article-title":"ETFAD\/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children","volume":"34","author":"Wollenberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4S","key":"10.1016\/j.ad.2023.02.011_bib0625","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jaci.2017.01.009","article-title":"Current guidelines for the evaluation and management of atopic dermatitis: a comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines","volume":"139","author":"Eichenfield","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0630","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.12638","article-title":"Clinical contraindications to allergen immunotherapy: an EAACI position paper","volume":"70","author":"Pitsios","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2023.02.011_bib0635","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000744","article-title":"Omalizumab as monotherapy for food allergy","volume":"21","author":"Arasi","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0640","doi-asserted-by":"crossref","first-page":"100519","DOI":"10.1016\/j.waojou.2021.100519","article-title":"Targeting immunoglobulin E in atopic dermatitis: a review of the existing evidence","volume":"14","author":"Wollenberg","year":"2021","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.ad.2023.02.011_bib0645","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ACI.0000000000000781","article-title":"Update on omalizumab in allergen immunotherapy","volume":"21","author":"Dantzer","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2023.02.011_bib0650","doi-asserted-by":"crossref","first-page":"100690","DOI":"10.1016\/j.waojou.2022.100690","article-title":"The rationale for development of ligelizumab in food allergy","volume":"15","author":"Wood","year":"2022","journal-title":"World Allergy Organ J"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023001643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023001643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:15:31Z","timestamp":1757553331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731023001643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0001731023001643"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.02.011","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Haptens, Proteins, and Atopic Dermatitis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2022.11.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}